Skip to main content
NC3Rs: National Centre for the Replacement Refinement & Reduction of Animals in Research
Online

Technology Partn3Ring webinar: Oncology technologies

-

Registration Details

Event date and time
-
Organiser
NC3Rs

Our Technology Partn3Ring webinar series showcases technologies with 3Rs potential to the wider scientific community to identify new partners for further development and use. Open to researchers, clinicians, pharmaceutical and industry professionals, each webinar features short pitches outlining 3Rs research, tools and technologies. Attendees can ask questions and have the opportunity to connect with the speakers to access the showcased technologies.

The next session will focus on 3Rs technologies to advance oncology research. Oncology is the third largest area of animal use for basic research in the UK and there are significant opportunities to develop alternative models that better represent cancer in human patients.

Registration will close 24hrs before the scheduled start time of the webinar.

Speakers

  • Patient-derived organoid model for oncology drug testing.
    Dr Chloé Prunier, INOVOTION.
  • Drosophila screening service for therapeutics.
    Dr Nicole Dawney, RxCelerate.
  • ATMS Dynamic Culture platform.
    Dr Vanessa Zaiatz Bittencourt, Taihoya.
  • 3D bioprinted bone marrow-leukaemia co-culture organoids.
    Dr Deepali Pal, University of Bristol.
  • Animal free peptide hydrogel for 3D cell culture.
    Dr Viola Erdelyi, Peptimatrix.
  • Chorioallantoic membrane (CAM) assay. 
    Professor Judy M Coulson, University of Liverpool.

Researchers in this area can also engage with our Oncology Network that supports scientists from across sectors to establish collaborations and catalyses the uptake of 3Rs technologies.